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Scheme 1.
1. Introduction and Scope 
A huge variety of indole alkaloids are known,
1-7
1234567many of 
which have been submitted to total synthesis. This review 
concerns the chemistry of indole alkaloids related to 
macroline 1, sarpagine 2 and ajmaline 3. The structures of 
these three species are shown in Scheme 1.  
The skeletal numbering shown is the biogenetic numbering 
proposed
8
 by LeMen and Taylor and is used throughout 
this review. It may be seen that there is significant 
structural similarity between the three compounds. All 
possess an indole-annulated azabicyclo[3.3.1] structure and 
various efforts towards this structural motif are detailed 
below. Macroline-related alkaloids are defined as those 
having the same skeletal connectivity as macroline. They 
crucially do not possess an N4-C21 linkage. Sarpagine-
related alkaloids are defined as those having the same 
skeletal connectivity as sarpagine, specifically with an N4-
C21 linkage and the C16-(R) configuration shown. 
Ajmaline-related alkaloids are defined as those having the 
same skeletal connectivity as ajmaline, also with an N4-
C21 linkage but with the C16-(S) configuration epimeric to 
that of sarpagine as shown. Alkaloids with a quaternary 
C16 are known and are included herein. There also may or 
may not be a C7-C17 linkage, the quaternary C7 implied 
thus rendering the C2-C7 bond saturated. Additionally, the 
compounds under consideration may or may not be N1- 
and N4-substituted and may or may not possess indole ring 
oxygenation. Bis(indole) alkaloids in which one or both of 
the subunits consist of a macroline/sarpagine/ajmaline 
indole base are also included in this review. 
It must be noted that, unlike ajmaline and sarpagine, 
macroline has not been isolated from natural sources. Many 
macroline-related alkaloids have, however, been isolated 
and it is believed that macroline, or an equivalent, is a 
likely biosynthetic precursor of various sarpagine alkaloids.  
Scheme 2. 
One can envisage the relationship in a synthetic sense, with 
1,2- or 1,4- addition of N4 to C19 or C21, respectively, 
providing access to the sarpagan skeleton. Such a synthetic 
strategy has been employed in some of the total syntheses 
detailed herein. The reverse transformation may also be 
envisaged – quaternisation of N4, followed by Hofmann 
elimination (provided C20 has an appropriate hydrogen, 
e.g. in ajmaline) resulting in N4-C bond scission. This 
strategy has also been adopted in total synthesis, as will be 
seen, and interconversions of this nature are important in 
structural elucidation and stereochemical correlation.  
The field of macroline, sarpagine and ajmaline-related 
alkaloids was reviewed extensively by Cook
9,10
 in 1993 and 
1994 and again by Lounasmaa
11,12
 in 1999 and 2001. As 
well as detailing reported synthetic endeavours relevant to 
the field, these excellent reviews give a comprehensive 
account of the species from which these alkaloids have 
been isolated (mostly genera Rauvolfia and Alstonia) and 
an overview of their biology, pharmacology, spectroscopic 
characteristics and proposals for their biosyntheses. Only 
chemistry of particular relevance, as well as that reported 
subsequent to these prior reviews or that not covered 
therein, is included here. 
2. Cook’s Syntheses 
Cook and co-workers have published extensively in the 
area of indole alkaloids and, in the last decade, have 
reported the partial and total syntheses of more than 40 
macroline/sarpagine/ajmaline-related alkaloids, as well as 
bis(indole) alkaloids and related degradation products. 
These syntheses are detailed in this section and are grouped 
by the methodology used, as opposed to the final targets in 
question. 
2.1. The tetracyclic ketone  
 
Fundamental to Cook’s syntheses is the tetracyclic ketone 
intermediate 10. Its synthesis has been reviewed before,
9,11
 
but will be detailed here also due to its relevance to the 
following sections. The overview of the synthesis is shown 
in Scheme 2. 
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The synthesis outlined above, whilst only seven steps, 
hasbeen the subject of extensive study and optimisation.
13
 
The individual steps merit consideration in detail. Starting 
from unnatural D-tryptophan 4, N1-methylation and 
esterification were routine. The reductive amination to 
protect N4, however, required careful control. After stirring 
5 with benzaldehyde for 2 h at room temperature to form 
the imine, sodium borohydride was added at –5 °C and 
allowed to react for 3 h. Longer reaction times or higher 
reaction temperatures led to erosion of the ee of 11 by 
imine isomerisation to 13 via 12 (Scheme 3). 
Scheme 3. 
The Pictet–Spengler condensation (and subsequent 
esterification) shown in Scheme 2 is represented as 
affording solely the C3,C5-trans tetrahydro-β-carboline 8. 
In fact a more complex series of events was occurring. As 
shown in Scheme 4, the initial Pictet–Spengler cyclisation 
proceeded to give a diastereoisomeric mixture of 
tetrahydro-β-carboline diacids 14. These underwent 
decarboxylation as shown and it was therefore the 
protonation upon rearrangement of intermediate 15 that 
determined the diastereoisomeric ratio in the product, not 
the inherent selectivity in the Pictet–Spengler reaction. 
Scheme 4. 
If the tetrahydro-β-carboline monoacid intermediates 16 
were isolated, the diastereoisomeric ratio was found to be 
C3,C5-cis:trans=42:58. Alternatively, if methyl 3-
formylpropionate 17 was used in place of 2-ketoglutaric 
acid 7, the diastereoisomeric ratio in 21 was found to be 
C3,C5-cis:trans=28:72 (Scheme 5). This enhanced 
diastereoisomeric ratio was observed due to the lack of a 
post-cyclative decarboxylation step; in this instance, the 
ratio is a true representation of the inherent selectivity of 
the Pictet–Spengler cyclisation. 
Scheme 5. 
Whilst the reaction of methyl 3-formylpropionate 17 with 6 
increased the diastereoselectivity in the formation of 21 via 
18-20, total selectivity was desired in order that tedious 
chromatography might be avoided and the sequence might 
be executed on a large scale. This was achieved by acid-
catalysed isomerisation of the C3,C5-cis isomer to the more 
stable C3,C5-trans isomer, simply by treating the 
diastereoisomeric mixture 16 or 21 with methanolic HCl 
(for 16, this also effected esterification). The isomerisation 
of 22 is thought to proceed via a C3-N4 bond cleavage and 
formation of stabilised C3 cation 23 (Scheme 6). 
Scheme 6. 
With pure 8 in hand, Dieckmann condensation to the 
tetracyclic system 9 was effected with sodium methoxide. 
The C3,C5-trans-configured tetrahydro-β-carboline 8 is 
unable to attain a conformation suitable for cyclisation, and 
so base-induced epimerisation of C5 must occur prior to 
cyclisation. Whilst the cis tetrahydro-β-carboline 24 is the 
less stable diastereoisomer (as established in Scheme 6), 
the small amount formed is irreversibly transformed to the 
tetracycle, the equilibrium then replenishes the amount of 
24 present and so all material is eventually transformed into 
tetracycle 9 (Scheme 7). The epimerisation prior to 
Dieckmann cyclisation is the reason Cook’s synthesis 
commences with the unnatural amino acid antipode. This 
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(incorrect) initial C5 configuration induces the correct C3 
configuration which, in turn, induces complete 
epimerisation at C5 to the correct configuration. 
Scheme 7. 
The uncontrolled configuration of C15 in 9 is of no 
consequence as acid-induced decarboxylation leads to key 
tetracycle 10 (7 steps from D-tryptophan, 47% overall 
yield). Cook’s group have routinely performed this 
synthetic sequence on a 100-gram scale. As not all 
macroline/sarpagine/ajmaline alkaloids are N1-substituted, 
the tetracyclic ketone 32 has also been prepared
14
 from 25 
with a free N1-H. The synthesis was complicated by 
unwanted lactam formation, as shown in Scheme 8. 
Scheme 8. 
Acid/methanol-induced transformation of 27 to 29 did not 
occur, probably because the lactam moiety would 
destabilise the α-aryl cation intermediate. The reaction 
occurred as desired in the absence of a free carboxyl group, 
using 28 to give 29. Upon exposure to base, 29 initially 
formed lactam 26, but eventually gave the desired 
Dieckmann product 31 via 30. Decarboxylation as before 
gave 32 (Scheme 9). 
 
Scheme 9. 
2.2. α,β-Unsaturated aldehyde formation and Claisen 
rearrangement: alstonerine, anhydromacrosalhine-
methine and macrocarpamine 
The tetracyclic ketone 10 was elaborated by Cook’s group 
in the first total synthesis of (–)-alstonerine,15 as shown in 
Scheme 10. Exchange of the N4-benzyl group for methyl to 
give 33 and elaboration of the ketone gave α,β-unsaturated 
aldehyde
16
 36 (via  34 and the intermediate epoxide 35). 
Scheme 10. 
Studies had shown that intermolecular addition to the C15 
position of 36 was not a facile process, so an intramolecular 
strategy was used. Reduction of 36 to 37 and formation of 
vinylogous ester 39 using 38 allowed C15 functionalisation 
via a Claisen rearrangement to give 40 (Scheme 11). 
Scheme 11. 
Carbonyl reduction and hydroboration gave triol 42 via 41, 
and then selective tosylation of a primary alcohol and 
cyclisation gave 43. A modified Swern oxidation
17
 
regenerated the vinylogous ester functionality and so led to 
(–)-alstonerine 44 (along with 31% dihydroalstonerine) in 
8% overall yield from tetracyclic ketone 10 (not 
considering recycling of material) or 4% overall yield from 
D-tryptophan (Scheme 12). 
Scheme 12. 
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The strategy detailed above for the synthesis of (–)-
alstonerine 44 was later extended by Cook et al. for the 
synthesis
18,19
 of (–)-anhydromacrosalhine methine 46. 
Whilst not a natural product, this indole base constitutes the 
indole unit of the macroline-related bis(indole) alkaloid (–)-
macrocarpamine 48. Reduction of (–)-alstonerine 44 gave 
secondary alcohol 45, which underwent acid-induced 
elimination to give (–)-anhydromacrosalhine methine 46. 
Coupling of 46 with a natural sample of pleiocarpamine 47 
(Scheme 13) completed the partial synthesis of (–)-
macrocarpamine 48 (2% overall yield from D-tryptophan). 
Scheme 13. 
2.3. Ajmaline and alkaloid G 
2.3.1. First-generation syntheses: 1,4-addition, 
oxyanion-Cope rearrangement and selective oxidations 
Cook and co-workers employed the tetracyclic ketone 10 in 
the first total synthesis of (–)-ajmaline.20,21 Ketone 10 was 
elaborated into α,β-unsaturated aldehyde 49 as before, 
although the reaction was found to proceed in the absence 
of the phosphine oxide (also the N4-benzyl group was still 
in place). As mentioned in Section 2.2, intramolecular C15 
functionalisation had been found to be difficult, but it 
transpired that successful organometallic addition was 
possible by use of a Barbier–Grignard process. A pseudo-
symmetric allyl bromide 50 was used to circumvent 
ambiguity regarding α- versus γ- addition. A mixture of 
1,2- and 1,4-addition products resulted, as shown, but, in an 
elegant resolution to this problem, Cook was able to 
transform the undesired 1,2-addition product 51 into the 
1,4-addition product 52 by means of an oxyanion-Cope 
rearrangement (Scheme 14). 
Scheme 14. 
From the initial Barbier–Grignard reaction, 51 and 52 were 
formed in a ratio of 51:49. Of this, the 1,4-addition product 
52 was formed in a ratio of 52a:52b of 3:1, where 52a was 
the desired isomer having the (15S) configuration. When 51 
underwent an oxyanion-Cope rearrangement, 52a and 52b 
were isolated in a ratio of 3:2. Subsequent elaboration of 
52a was by ethylidene acetal protection of the aldehyde 
(giving 53) and oxidative cleavage of the olefin. In order to 
effect chemoselective cleavage in the presence of the 
oxidatively-sensitive indole, a stoichiometric osmylation 
was required, with subsequent periodate cleavage of the 
resultant diol. At this point in the sequence it was possible 
to epimerise C20 via the aldehyde enolate, giving a 
54a:54b 1:1 epimeric mixture, separable by 
chromatography. With recycling of the undesired epimer 
54b, >80% conversion from 53 was possible (Scheme 15). 
Scheme 15.  
N4-deprotection allowed formation of the O-acetyl aminal 
55. Treatment with HCl(aq)/AcOH, then Ac2O/HCl(g), 
effected the final cyclisation to the ajmalan skeleton by 
electrophilic addition to C7. The resultant C2 hemiaminal 
56 was reduced under Lewis acidic conditions to furnish a 
C2-epimeric mixture, 57a:57b of 2:3. The epimer having 
the correct C2 configuration, 57a, underwent base-
mediated hydrolysis to afford (–)-ajmaline 3 (Scheme 16) 
in 11% yield from tetracyclic ketone 10 (5% from D-
tryptophan). Whilst the formation of only 40% of the 
desired C2 epimer in the penultimate step is not ideal, Cook 
notes that 2-epi-diacetyl ajmaline 57b is the 
thermodynamic product and many reagent systems provide 
solely 57b. 
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Scheme 16. 
Hydrolysis of acetal 55 gave 58, which had previously been 
converted via 59 into alkaloid G by Stöckigt and co-
workers
22
 (Scheme 17), employing a DDQ oxidation to 
functionalise the C6 position. Cook’s report therefore 
constitutes a formal synthesis of alkaloid G 60 in 10 steps 
and 12% yield from tetracyclic ketone 10 (6% overall yield 
from D-tryptophan). 
Scheme 17. 
2.3.2. Second-generation syntheses: organobarium 
chemistry and kinetic enolate quenching 
Shortly after the reports summarised in Section 2.3.1, 
Cook’s group published improved syntheses of (–)-
ajmaline
23
 and alkaloid G.
23,24
 The improvements address 
the issue of stereocontrol in the organometallic addition and 
oxyanion-Cope steps. Using methodology due to 
Yamamoto,
25
 Cook and co-workers treated N1-
unsubstituted α,β-unsaturated aldehyde 61 with an 
organobarium reagent derived from (E)-pent-2-enyl 
bromide 62. This addition took place solely from the α-
position of the metallate, hence the need for a pseudo-
symmetric alkenyl halide was removed. Additionally, only 
1,2-addition to 61 was observed, giving 63 as the sole 
product (Scheme 18). 
Scheme 18. 
Oxyanion-Cope rearrangement of 63 took place as before; 
in this instance, however, near total selectivity for the 
desired configurations was observed at C15 and C20 (c.f. 
selectivity of 3:2 in Section 2.3.1). At C16, in the first 
instance, the selectivity was 1:4 for 64a:64b for the 
undesired sarpagan (16R) configuration. Upon prolonged 
exposure of (16S) 64a to base, epimerisation to mostly 
(16R) 64b was observed, implying 64b was the 
thermodynamic product (Scheme 19). 
 
Scheme 19. 
The 3D structure (Scheme 20) of the enolate resulting from 
the oxyanion-Cope rearrangement suggested that the α-face 
might be less hindered and as such 64a might be the kinetic 
product. After optimisation, it was found that quenching the 
oxyanion-Cope rearrangement with 1 N trifluoroacetic acid 
at low temperature favoured the formation of 64a. After the 
rearrangement had gone to completion, THF was added, 
allowing the reaction mixture to be cooled below the 
melting point of dioxane. At –100 °C in dioxane:THF, 
addition of 1 N trifluoroacetic acid in THF afforded 
64a:64b in a ratio of 43:1. 
 
 
 
Scheme 20. 
The ability 
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to vary reaction conditions to favour either 64a or 64b 
permits stereospecific entry to either the 
macroline/sarpagine (16R) series or the ajmaline (16S) 
series. Aldehyde 64a was protected as the ethylidene acetal 
and then N1-methylated to converge on the (–)-ajmaline 
synthesis detailed in Section 2.3.1. The second-generation 
synthesis was thus completed in 9% overall yield from D-
tryptophan methyl ester, an appreciable improvement. In 
completing the second-generation synthesis of alkaloid G, 
Cook’s laboratory reports a significant improvement to the 
DDQ-mediated α-aryl oxidation step – performing the 
reaction in wet THF leads to a yield of 94% of 42 (one 
diastereoisomer only). The improved alkaloid G synthesis 
was therefore completed in 25% overall yield from D-
tryptophan methyl ester. 
2.4. Selenium chemistry and an unusual pyrolytic 
rearrangement: talpinine, talcarpine, alstonerine and 
anhydromacrosalhine-methine 
Cook et al. have reported syntheses
26,27
 of the two 
structurally related macroline/sarpagine alkaloids, (–)-
talcarpine 65 and (–)-talpinine 66. They employ much of 
the methodology used for the synthesis of (–)-ajmaline and 
alkaloid G. It may be seen (Scheme 21) that 65 and 66 are 
epimeric at C20 and that 66 lacks the N4-methyl group, but 
has a hemiaminal moiety containing a C21-N4 linkage. 
Scheme 21. 
The synthetic sequence was executed as per Section 2.3.2, 
this time from the N1-unsubstituted tetracyclic ketone 32. 
As the sarpagan configuration (16R) was required in this 
instance, the enolate deriving from the oxyanion-Cope 
rearrangement was quenched under thermodynamic 
conditions, simply by adding MeOH to the reaction mixture 
and stirring at room temperature for 2 h to give 64b. After 
N1-methylation, the aldehyde moiety was reduced and 
oxidative olefin cleavage (as previously) this time afforded 
a diastereoisomeric mixture of lactols 68, which were then 
dehydrated (Scheme 22). 
Scheme 22. 
A key feature of this synthesis is the use of N-
(pehnylseleno)phthalimide to effect the addition of 
selenium
28
 and a methoxy group across the enol ether, 
giving 709, followed by selenium oxidation and elimination 
with rearrangement to afford a mixture of exocyclic olefin 
geometries (Scheme 23) in a ratio 71a:71b of 4:1 (where 
71a is the desired isomer). 
 
Scheme 23. 
The desired isomer 71a was treated with 5% H2SO4 for 3 
days, which induced acetal opening, C15-C20 bond 
rotation and Michael addition, to generate saturated C20-
aldehydes as a C20 epimeric mixture, 3:5 of 72a:72b. 
Aldehyde 72a (20R configuration) is the precursor of 
talpinine and, similarly, 72b (20S configuration) is the 
precursor of talcarpine. The two epimeric precursors may, 
in fact, be interconverted (Scheme 24). 
Scheme 24. 
Conversion of 72a into 72b is simply base-induced 
epimerisation to the thermodynamic product. The pyrolytic 
conversion
29
 of 72b into 72a is not fully understood 
mechanistically. Conversion of 72a into talpinine (10% 
from D-tryptophan, Scheme 25) was effected simply by N4-
debenzylation (with spontaneous hemiaminal formation). 
Conversion of 72b into talcarpine (10% from D-tryptophan, 
Scheme 25) was effected by N4-debenzylation with 
concomitant N4-methylation, a transformation speculated 
to involve in-situ formaldehyde formation. 
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Scheme 25. 
The methodology detailed above has also been employed in 
the second-generation syntheses
27
 of anhydromacrosalhine-
methine and alstonerine. The geometric mixture of olefins 
(71a and 71b) was subjected to hydroboration, Swern 
oxidation, elimination of methanol and N4-
debenzylation/methylation to furnish (–)-alstonerine 44 
(Scheme 26) via 73 and 74 in an improved 12% overall 
yield from D-tryptophan (c.f. Section 2.2). 
Scheme 26. 
Anhydromacrosalhine-methine 46 was synthesised from 69 
(Scheme 27), by N4-debenzylation/methylation at an 
earlier stage, then selenium introduction, oxidation and 
elimination as before, followed by acid-induced elimination 
to the vinylogous enol ether product 46 via 75 and 76 (14% 
from D-tryptophan, c.f. Section 2.2). 
 
 
 
 
 
 
 
Scheme 27. 
2.5. Pyridine formation: norsuaveoline 
Cook’s laboratory has also reported the synthesis of the 
pyridyl macroline alkaloid, norsuaveoline.
21,30
 This 
synthesis has much in common with Cook’s earlier 
synthesis of suaveoline.
31
 From the N1-unsubstituted 
tetracyclic ketone 32, the synthesis proceeded as per the 
ajmaline synthesis in Section 2.3.2. Cook and co-workers 
opted to use the sarpagan C16-configured oxyanion-Cope 
product, although, in this instance, the configurations of 
C15, C16 and C20 are of less concern, since all are 
ultimately incorporated into the pyridine ring. Ethylidene 
acetal formation and oxidative olefin cleavage were 
executed as before to give 77. In this case, however, the 
acetal was deprotected to furnish a 1,5-dialdehyde 78. This 
was treated with ethanolic hydroxylamine hydrochloride to 
access the pyridine ring directly; N4-debenzylation of 79 
afforded norsuaveoline 80 in 28% yield from D-tryptophan 
methyl ester (Scheme 28). 
Scheme 28. 
 
2.6. Palladium sarpagan methodology: ent-affinisine, 
16-epi-affinisine, alkaloid Q3, dehydro-16-epi-affinisine, 
koumidine, 16-epi-N-methylpericyclivine, N-
methylvellosimine, normacusine B, 16-epi-normacusine 
B, panarine and vellosimine 
For the synthesis of alkaloids possessing the sarpagan 
skeleton, a key question is how to construct the skeleton 
such that the C19-C20 olefin geometry is controlled. Cook 
attempted to address this problem in various ways and met 
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with success when he employed a palladium-mediated 
cyclisation. The key reaction may be illustrated with the 
example of Cook’s total synthesis32,33 of (+)-vellosimine 
85. The iodoalkene 82 (which has been employed by other 
workers
34-40
) 34353637383940was reacted with the N1-unsubstituted, N4-
debenzylated tetracyclic ketone 81 to give 83 (Scheme 29). 
Scheme 29. 
Ketone 83 was elaborated to the corresponding α,β-
unsaturated aldehyde 84, as previously. One can envisage 
that transmetallation and Michael addition would give 
access to the sarpagan skeleton, but, in fact, this approach 
was unsuccessful. Instead, it was found that a radical-
mediated coupling could effect C15-C20 bond formation. 
This occurred with scrambling of the C19-C20 olefin 
geometry, however, and the desired (+)-vellosimine 85 was 
the minor product in a ratio 85:86 of 1:3 (Scheme 30). 
Scheme 30. 
In view of the failure of both metallate and radical 
methods, the desired stereospecific cyclisation of 84 was 
attempted under Pd
0
 catalysis. The unexpected product 87 
was isolated (as a single geometric isomer), presumably 
arising from the enolate of 84. Such a cyclisation had been 
previously observed in other systems.
41
 By inference from 
this result, it followed that 83 might undergo cyclisation to 
the desired vellosimine skeleton. Ketone 83 did, indeed, 
give 88 stereospecifically under the same conditions. This 
was transformed into (+)-vellosimine 85 via a masked 
aldehyde, which was unmasked and epimerised to the more 
stable C16 sarpagan configuration (Scheme 31). The first 
total synthesis of this sarpagine alkaloid was therefore 
completed in 27% overall yield from D-tryptophan methyl 
ester. 
 
 
 
Scheme 31. 
Several 
more 
sarpagine 
alkaloids
33,42
 
were, in 
turn, 
synthesised 
from 
(+)-vellosim
ine 85 
(Scheme 
32). 
Reduction 
of the 
aldehyde in 
85 gave (+)-
normacusine 
B 89 (24% 
from 
D-tryptopha
n methyl 
ester). Conversely, oxidation of the aldehyde in 85 and 
esterification gave 90, quaternisation of which with methyl 
iodide (to furnish 91) and subsequent anion exchange gave 
(–)-alkaloid Q3 92 (18% from D-tryptophan methyl ester). 
Ester hydrolysis of 92 and neutralisation gave zwitterionic 
(–)-panarine 93 (16% from D-tryptophan methyl ester). 
Scheme 32. 
The same synthetic sequence used to prepare (+)-
vellosimine was applied to the N1-methyl tetracyclic 
ketone 10 to produce (+)-N-methylvellosimine
33
 94 (29% 
overall yield from D-tryptophan, Scheme 33). Oxidation 
and esterification provided (+)-N-methyl-16-epi-
pericyclivine
33
 95 (27% overall yield from D-tryptophan).  
Reduction of the aldehyde in 94 provided (+)-affinisine
33
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97 (26% overall yield from D-tryptophan). Cook’s group 
also executed the entire synthetic sequence from L-
tryptophan, via 96, thus providing ent-97 (–)-affinisine,43 
the enantiomer of the natural product (Scheme 33). This 
ent-affinisine was required for the synthesis of 
―mismatched‖ unnatural bis(indole) alkaloids, to probe 
their biological activities and SAR. As LeQuesne had 
previously reported
44,45
 partial syntheses of macroline 1 and 
alstonerine 44 from affinisine, Cook’s work constitutes 
formal syntheses of the antipodes of these alkaloids also. 
Scheme 33. 
A slightly different approach was used to access sarpagine 
alkaloids possessing the opposite configuration at C16 
(ajmaline configuration). From sarpagan C16 ketone 88, 
Wittig methylenation and selective hydroboration of the 
disubstituted olefin from the less hindered face gave 16-
epi-normacusine B
24,46
 99 (26% from D-tryptophan methyl 
ester). In the N1-methyl series, from sarpagan C16 ketone 
100, the same Wittig methylenation and selective 
hydroboration gave 16-epi-affinisine
24,46
 101 (25% from D-
tryptophan methyl ester). DDQ-mediated α-aryl oxidation 
gave dehydro-16-epi-affinisine
24,46
 102 (24% from D-
tryptophan methyl ester), as shown in Scheme 34. 
 
 
Scheme 34. 
Cook 
employed a 
modified 
version of 
the 
palladium-
catalysed 
coupling 
in the 
synthesis
47
 
of (–)-
koumidine 
109, 
which differs from the various species shown above in that 
the geometry of the C19-C20 olefin is (Z). To access this 
alternative geometry, the alternate iodoalkene 105 was 
synthesised from 103 via 104 as shown in Scheme 35 and 
coupled 
to N1-
unsubsti
tuted 
tetracyc
lic 
ketone 
81. 
Scheme 35. 
The palladium-mediated cyclisation was less facile than in 
previous examples with the opposite (E) olefin geometry – 
despite much optimisation, on reaction of 106 significant 
amounts of dealkylated product 81 were isolated along with 
the desired 107. Completion of the synthesis (Scheme 36) 
was via hydroboration of 108 as for the other C-16-epi 
alkaloids, in 21% yield from D-tryptophan methyl ester. 
Scheme 36. 
2.7. Selective hydroboration: trinervine 
The sarpagine alkaloid trinervine 113, a cyclic hemiacetal, 
was synthesised from (+)-normacusine B 89, the synthesis 
of which is detailed in Section 2.6. Silylation of the alcohol 
was followed by attempts at selective hydroboration of the 
trisubstituted C19-C20 olefin (Scheme 37). Surprisingly, 
the initial selectivity (at 0 °C) for the secondary hydroxyl 
product 111 over the tertiary regioisomer was only 7:3. It 
was postulated that this may be due to complexation of the 
first equivalent of borane to N4, thus altering the electronic 
characteristics of the olefin. A detailed optimisation study 
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was carried out
48
 – use of bulky hydroborating agents 
resulted in no reaction, but increased selectivity was 
observed by using 110 (with R = TIPS) at room 
temperature, furnishing the desired regioisomer in a ratio of 
25:1. This was oxidised, in turn, to the ketone and upon 
deprotection of the hydroxyl group in 112 (and cleavage of 
the borane adduct), spontaneous cyclisation gave trinervine 
113 (20% from tetracyclic ketone 32). 
Scheme 37. 
 
2.8. Indole oxygenation 
As alluded to in the introduction, many 
macroline/sarpagine/ajmaline alkaloids possess indole ring 
oxygenation. Cook has synthesised many of these and the 
key to these syntheses has been the optimisation of routes 
to the relevant oxygenated tryptophan derivatives. Cook 
has successfully introduced oxygenation in the C10-, C11- 
and C12-positions. In each instance, the Schöllkopf chiral 
auxiliary
49
 was used to introduce the correct amino acid 
stereochemistry. The precise details vary depending on the 
ring substitution pattern, however, and so will be discussed 
individually. 
2.8.1. C10 oxygenation: majvinine, 10-
methoxyaffinisine, N-methylsarpagine and 
macralstonidine 
p-Anisidine was employed as a starting material for a 
synthesis
50,51
 that Cook’s laboratory has executed on a 
> 600-gram scale (Scheme 38). Fischer indole formation 
via a Japp–Klingemann azo-ester intermediate52,53 formed 
from 114 and 115 gave the trisubstituted indole 116. C2-
Decarboxylation to give 117 was followed by N1-
protection, either with a Boc group (giving 118) or as a 
sulfonamide (only the Boc series is considered here). 
Optimisation of the brominating conditions
51
 was required 
to access the desired α-aryl brominated product 119 and 
avoid indolyl C2-bromination. 
Scheme 38. 
Cook has studied the effect of the leaving group and other 
parameters on the diastereoselectivity of the reaction with 
Schöllkopf auxiliaries.
54,55
 Bromide 119 was coupled with 
the Schöllkopf auxiliary 120 (derived from L-valine) to 
give 121 as a single diastereoisomer. The Boc group was 
cleaved thermolytically, followed by N1-methylation in 
one pot, giving 122. The auxiliary was removed under 
conditions of acidic hydrolysis to furnish 123, the C10-
methoxy analogue of D-tryptophan ethyl ester (Scheme 39). 
 
 
Scheme 39. 
The ring-oxygenated amino acid 123 was amenable to the 
chemistry developed by Cook and co-workers detailed in 
Sections 2.1 to 2.7. Thus, the synthesis of C10-methoxy 
tetracyclic ketone 124 was high yielding (although it was 
necessary to avoid harshly acidic conditions in the Pictet–
Spengler and C3-isomerisation steps, otherwise 
decomposition of the indole occurred). The conversion of 
124 to the sarpagan skeleton via the palladium enolate 
methodology described previously was similarly high 
yielding (Scheme 40). Synthesis of (+)-majvinine 125 (28% 
yield from C10-methoxy D-tryptophan ethyl ester analogue 
123) was executed as per N-methylvellosimine 94 
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(majvinine is simply the C10-methoxy analogue of 94). 
Reduction    of    the    aldehyde    moiety    in    125    gave 
Scheme 40. 
(+)-10-methoyxaffinisine 126 (25% yield from 123). For 
the synthesis of (+)-N-methylsarpagine 128, a C10-hydroxy 
group was required as opposed to a C10-methoxy group. 
Therefore, (+)-majvinine 125 was demethylated with boron 
tribromide (giving 127) prior to reduction to (+)-N-
methylsarpagine 128 (20% yield from 123). 
Cook also reported the first total synthesis of the 
bis(indole) alkaloid, (+)-macralstonidine 129, from the 
coupling
45
 of synthetic N-methylsarpagine 128 with 
synthetic macroline 1 (Scheme 41). 
Scheme 41. 
2.8.2. C11 oxygenation: gardnerine, gardnutine, 11-
methoxyaffinisine and 16-epi-N-methylgardneral 
Synthesis of a C11-oxygenated tryptophan analogue would 
have been subject to regiochemical ambiguity if attempted 
via a Fischer indole formation. Cook and co-workers 
accessed   this   series
56
 by   means   of   a   Larock   hetero- 
Scheme 42. 
annulation.
57
 The order of events is reversed from that in 
Section 2.8.1, in that reaction of 130 with the Schöllkopf 
auxiliary occurs prior to indole formation with 132 to give 
133 (Scheme 42). The formation of 131 in high de is due in 
part to the choice of phosphonate leaving group.
54
 The 
Larock heteroannulation has been carried out on a 300-
gram scale. 
Both N1-methyl and N1-unsubstituted amino acids are 
easily accessible by this method. Once again, Cook’s 
previously developed methodology was viable with these 
C11-oxygenated amino acids (Scheme 43): (+)-16-epi-N-
methylgardneral 137 was synthesised via 136 (35% from 
C11-methoxy, N1-methyl D-tryptophan ethyl ester 135) as 
per N-methylvellosimine 94 (Section 2.6, 137 is simply the 
C11-methoxy analogue of 94). Reduction of 137 gave 11-
methoxyaffinisine 138 (32% from 91). Note that 137 and 
138 have not been isolated from a natural source to date; 
they are precursors of natural products discussed in 
Sections 2.11 and 2.12. 
Scheme 43. 
(–)-Gardnerine 139 and (+)-gardnutine 140 are N1-
unsubstituted C11-methoxy sarpagine alkaloids synthesised 
from C11-methoxy D-tryptophan ethyl ester 134 by Cook 
and co-workers
58
 in a manner analogous to that for 16-epi-
normacusine B 99 (Section 2.6, 139 is simply the 11-
methoxy analogue of 99).  (–)-Gardnerine 139 was 
synthesised in 20% overall yield from 134. (+)-Gardnutine 
140 was synthesised from 139 by DDQ-mediated α-aryl 
oxidation (18% overall yield from 134, Scheme 44). 
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Scheme 44. 
2.8.3. C12 oxygenation: fuchsiaefoline, 12-
methoxyaffinisine and 12-methoxy-N-methylvellosimine 
The required C12-methoxy amino acids were prepared by 
the same process used for the C11-methoxy series (namely 
a Larock heteroannulation), employing a regioisomeric 
iodoanisidine 141, giving 142 as a common intermediate 
for the synthesis of 143 and 144 (Scheme 45). 
Scheme 45. 
The C12-methoxy amino acids were compatible with 
Cook’s previously developed methodology, thus permitting 
the synthesis
59,60
 of (+)-12-methoxy-N-methylvellosimine 
145 (overall yield 40% from 144) and (+)-12-
methoxyaffinisine 146 (overall yield 38% from 144) as per 
the unsubstituted analogues 85 and 97. The quaternary 
alkaloid (–)-fuschiaefoline 148 was synthesised via 147 
(27% yield from 144) in two steps from 145 (Scheme 46). 
Scheme 46. 
2.9. Hofmann elimination: alstophylline, ent-macroline, 
11-methoxymacroline, macralstonine 
As mentioned in the introduction, the macroline skeleton 
may be accessed by Hofmann elimination of the sarpagine 
skeleton, a transformation used by Cook to synthesise 
many macroline alkaloids. For example,
61
 starting from 
L-tryptophan, Cook et al. synthesised 149, the enantiomer 
of the N1-methyl analogue of C19-oxo borane adduct 112 
from the synthesis of trinervine (Section 2.7). Whereas in 
the trinervine synthesis 112 was treated with excess acid to 
effect both dative bond scission and desilylation, in this 
instance 149 was treated with a small excess of acid, 
removing the borane, but leaving the silyl group intact to 
give 150. N4 was quaternised with methyl iodide, then 
under basic conditions Hofmann elimination occurred with 
regiospecific N4-C21 bond scission to give O-silylated 
macroline derivative ent-151. This was stable upon storage, 
or could be deprotected to give reactive (–)-macroline, ent-
1 (Scheme 47), in 12% overall yield from L-tryptophan 
methyl ester (intended for use in the synthesis of 
mismatched bis(indole) alkaloid analogues). 
Scheme 47. 
11-Methoxymacroline 155 was synthesised
56
 by an entirely 
analogous route from the (naturally configured) 11-
methoxy amino acid ester 134 (detailed in Section 2.8.2) in 
14% overall yield. (–)-Alstophylline 158 (the 11-methoxy 
analogue of alstonerine 44) was also synthesised by this 
route
56
 – in this case, two possible pathways were available, 
only one of which utilised 11-methoxymacroline 155 as an 
intermediate (via 152, 153 and 154, Scheme 48), the other 
being via 156. The final step in the synthesis of (–)-
alstophylline 158 is an IBX-mediated oxidation of common 
intermediate 157. Note that the yields are not quoted for all 
steps (preliminary communication). The bis(indole) 
alkaloid, macralstonine 159, was synthesised by the 
protocol of LeQuesne and Cook
62
 from macroline and 
alstophylline monomer units (Scheme 49). 
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2.10. Diastereospecific oxindole formation: alstonisine 
Brief consideration will be given to Cook’s synthesis of the 
macroline-related oxindole (+)-alstonisine 163. Oxindoles 
may be formed from the corresponding indoles by C2-C7 
oxidation, with rearrangement to the C7-spirocyclic 
skeleton in the case of tetrahydro-β-carbolines. Model 
studies performed by Cook
63
 on the tetracyclic ketone 10 
(Scheme 50) led to the discovery that if osmium tetroxide 
were used as oxidant, a particular diastereoisomer (160 or 
161) could be favoured by the presence or absence of a 
Sharpless ligand (quinuclidine, DHQ-CLB, DHQD-CLB, 
(DHQ)2PHAL and (DHQD)2PHAL were used). 
Cook applied the findings from the model studies to the 
synthesis
64
 of (+)-alstonisine. Acetal 74 (a late-stage 
intermediate from the second-generation synthesis of   
(–)-alstonerine 44, detailed in Section 2.4) was oxidised 
diastereoselectively to furnish oxindole 162 as the sole 
diastereoisomer. Cook proposes that coordination of the N4 
lone pair to the osmium enhances the selectivity. N4-
Debenzylation was followed by elimination to form the 
vinylogous ester product (+)-alstonisine 163 (12% overall 
yield from D-tryptophan, Scheme 51). 
  
Scheme 48. 
Scheme 49. 
Scheme 50. 
Scheme 51. 
 Tetrahedron 14 
2.11. Tollens reaction: dehydrovoachalotine, 11-
methoxy-17-epi-vincamajine and vincamajinine 
Various sarpagine/ajmaline-related alkaloids are known 
which have a quaternary C16 motif. To access this 
substitution pattern from tertiary C16 species such as those 
dealt with in Sections 2.6-2.8, Cook et al. employed the 
Tollens reaction. For example, in the synthesis
65,66
 of 
(+)-dehydrovoachalotine 167, N-methylvellosimine 94 was 
transformed into the 1,3-diol 164 in a yield of up to 90% 
after optimisation (Scheme 52). DDQ-mediated α-aryl 
oxidation was high yielding, as before, but oxidation of the 
neopentyl hydroxyl group in 165 proved problematic; 
eventually, it was found that a selenium-mediated oxidation 
furnished the aldehyde 166, which, in turn, could be 
oxidised to (+)-dehydrovoachalotine 167 (21% overall 
yield from D-tryptophan). 
Scheme 52. 
The Tollens reaction was also used by Cook and co-
workers in their syntheses
66,67
 of (–)-vincamajinine 172, 
and (–)-11-methoxy-17-epi-vincamajine 176. The synthesis 
of 172 (Scheme 53) also commenced with the 
transformation of N-methylvellosimine into the 1,3-diol 
164. To enable cyclisation to the ajmaline skeleton, a 
selective oxidation to a β-hydroxyaldehyde was needed. In 
the event, TPAP was able to selectively oxidise the less 
hindered hydroxymethyl group with diastereoselectivity 
> 10:1. Treatment of 168 with trifluoroacetic acid and 
acetic anhydride in a sealed tube effected the C7-C17 
cyclisation, giving 169, and then the unwanted C2-
hydroxyl was reduced to give 170. Completion of the 
synthesis of 172 (via 171) required several sequential 
oxidations and reductions – all attempts to combine these 
steps resulted in a dramatic drop in yield. (–)-
Vincamajinine 172 was obtained in 12% overall yield from 
D-tryptophan methyl ester. 
Scheme 53. 
The synthesis of (–)-11-methoxy-17-epi-vincamajine 176 
(Scheme 54) was broadly similar to that of 172, except that 
a ring-oxygenated precursor (N-methyl-16-epi-gardneral 
137) was employed. The Tollens reaction has been shown  
Scheme 54. 
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to be compatible with both C10 and C11 oxygenation.
65
 
(–)-11-Methoxy-17-epi-vincamajine 176 was obtained via 
173, 174 and 175 in an overall yield of 8% from 10-
methoxy D-tryptophan ethyl ester 123. Cook has also 
prepared
66
 related compounds such as quebranchidine diol, 
epimeric at C17. 
2.12. Modified Wacker oxidation: alstophylline, 6-
oxoalstophylline, alstonerine and macralstonine 
Cook has recently reported
68
 the use of a modified Wacker 
protocol
69
 to improve on the previous syntheses of the 
above-named alkaloids. For example, in the third 
generation synthesis of (–)-alstonerine, silylated macroline 
equivalent 151 (described in Section 2.9) undergoes 
deprotection and oxidative cyclisation directly to (–)-
alstonerine 44 in a palladium-catalysed process employing 
t
BuOOH as oxidant (Scheme 55). The yield of 60% is the 
result of optimisation work. 
Scheme 55. 
(–)-Alstonerine 44 was synthesised in 9% overall yield 
from D-tryptophan methyl ester. In a second-generation 
synthesis of (–)-alstophylline 158 (Scheme 56), the same 
protocol was applied to the corresponding 11-
methoxymacroline equivalent 154, affording 158 directly in 
55% yield. (–)-Alstophylline 158 was obtained in 9% 
overall yield from 11-methoxy amino acid ester 135. This 
improved synthesis of (–)-alstophylline also constituted a 
second-generation synthesis of macralstonine 159 (c.f. 
Section 2.9). Finally, to effect the first total synthesis of 
(+)-6-oxoalstophylline 181, silylated sarpagan borane 
adduct 177 underwent N4-B bond scission to give 178, and 
was then oxidised
70
 with excess IBX to effect not only C19, 
but also C6, ketone formation. Tertiary amine 179 
underwent Hofmann elimination as expected, giving 180,  
and the modified Wacker protocol furnished (+)-6-
oxoalstophylline in 10% overall yield from 11-methoxy 
amino acid ester 135. The mechanism of the modified 
Wacker oxidation has not yet been fully elucidated. 
 
 
Scheme 56. 
2.13. Lactol protection: 10-hydroxy-N-
methylpericyclivine, 10-methoxy-N-methylpericyclivine, 
12-methoxy-N-methylvoachalotine, N-
methylakuammidine and N-methylpericyclivine 
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Certain of Cook’s syntheses have been of sarpagine-related 
alkaloids that have required protection of C17. For 
instance, in the synthesis
71
 of N-methylpericyclivine 185, 
formation of the C17 ester was complicated by the fact that 
C16 epimerisation gave the more stable isomer, N-methyl-
16-epi-pericyclivine 95, under many ester-forming 
conditions. It was ascertained after experimentation that 
protection of the C17 aldehyde of 182 as a lactol (using the 
DDQ methodology outlined in Section 2.3.2) permitted 
oxidation of C17 (in 183) to the correct oxidation state (in 
184) with retention of the desired C16 configuration. 
Reductive deprotection of the lactone with Et3SiH and TFA 
and in-situ esterification gave the desired N-
methylpericyclivine 185 (10% overall yield from D-
tryptophan methyl ester). A similar approach
71
 starting 
from ring-oxygenated tryptophan derivative 123 afforded 
10-methoxy-N-methylpericyclivine 186 (9% from 123) and 
10-hydroxy-N-methylpericyclivine 187 (7% from 123), 
Scheme 57. 
Scheme 57. 
In the case of N-methylakuammidine
71
 192, the 
configuration at the quaternary C16 was retained by the 
same protection strategy. In this instance, protection of the 
hydroxyl moiety in the final product as an acetate was also 
indicated (via 188-191, Scheme 58). N-
methylakuammidine 192 was synthesised in 6% yield from 
D-tryptophan. 
A similar protection strategy was adopted in Cook’s recent 
synthesis
60
 of 12-methoxy-N-methylvoachlotine 198. In 
this instance, the protection was at a lower level of 
oxidation – as a cyclic ether, as opposed to a γ-lactol or 
lactone. 12-Methoxy-N-methylvellosimine 145 was 
subjected to the Tollens reaction as before to give 193, and 
then to the sequence of transformations effecting the 
protection (194), transformation (195 and 196) and 
deprotection (197); quaternisation furnished 12-methoxy-
N-methylvoachlotine 198 in 20% yield from 144, Scheme 
59. 
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Scheme 58. 
Scheme 59. 
3. Martin’s Biomimetic Synthesis of (+)-N-
Methylvellosimine 
Martin et al. have reported
72
 an enantiospecific total 
synthesis of N-methylvellosimine 94, which differs 
fundamentally from that of Cook in that formation of the 
C5-C16 bond is the final C-C bond-forming event (199, 
Scheme 60). 
Scheme 60. 
That such a reaction might occur in the biosynthesis of 94 
was first proposed by van Tamelen,
73,74
 a proposition 
supported by the subsequent report
75,76
 of a biogenetic-type 
synthesis of ajmaline involving just such a transformation. 
Later, Lounasmaa et al. attempted the cyclisation of similar 
iminium ions, but with no success.
77
 This led them to 
propose an alternative biosynthesis for the formation of the 
sarpagan skeleton, with C5-C16 bond formation as the 
penultimate skeletal bond-forming transformation and N4-
C21 bond formation as the final cyclisation. Partly to 
discern which pathway was most likely to operate, Martin 
and co-workers undertook the synthesis outlined below. 
Scheme 61. 
Martin’s synthesis (Scheme 61) commenced with the 
vinylogous Mannich reaction of dihydro-β-carboline 200 
(derived from D-tryptophan and formic acid in 60% yield) 
with silyl ketene acetal 201 to give tetrahydro-ß-carboline 
202 with total diastereoselectivity. Introduction of the 4-
carbon C18-21 fragment with diketene (and concomitant 
cyclising Michael addition) gave tetracycle 203. Stepwise 
borohydride reduction and elimination gave α,β-
unsaturated amide 204 as a single geometric isomer. N1-
methylation, amide reduction (giving 205) and selective 
ester hydrolysis gave the potential iminium precursor 206. 
It was decided to employ an α-aminonitrile as the actual 
iminium precursor, as these were known to furnish iminium 
ions under mild conditions. α-Aminonitrile 207 was thus 
synthesised by introduction of an amide at the C5 position 
and its subsequent dehydration (Scheme 62). 
Scheme 62. 
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α-Aminonitrile 207 was subjected to imine-generating 
conditions, but no C5-C16 cyclisation was observed. This 
was taken to mean that the ester was insufficiently 
activating and so it was converted into the aldehyde 208. 
This also was inert to cyclisation, but, upon formation of 
the corresponding silyl enol ether 209 and treatment with 
BF3·OEt2, cyclisation to the sarpagan skeleton was 
observed (Scheme 63). 
Scheme 63. 
The target was obtained as an epimeric mixture (7:3 (+)-N-
methylvellosimine:(+)-16-epi-N-methylvellosimine). As 
the desired natural epimer is the more thermodynamically 
stable, conversion into pure 94 was achieved by exposure 
of the mixture to aqueous KOH in MeOH. This elegant 
synthesis (7% overall yield from D-tryptophan) provides 
significant evidence for the feasibility of van Tamelen’s 
original biogenetic pathway. Furthermore, it points to the 
possibility that the total synthesis of other 
sarpagine/ajmaline alkaloids might be viable via such an 
iminium-induced cyclisation. 
4. Martin’s Olefin Metathesis Route to 
Azabicyclo[3.3.1]nonenes 
Martin et al. have conducted an extensive study
78
 on olefin 
metathesis as a method of accessing various 
azabicyclo[m.n.1] structures (m = 3-5, n = 2-3, with the 
nitrogen in the 1-atom bridge). Such structural motifs (211-
214) are common in alkaloids (Scheme 64). 
Scheme 64. 
An indole-annulated azabicyclo[3.3.1] structure constitutes 
the tetracyclic skeleton of the macroline/sarpagine/ajmaline 
alkaloids and Martin and co-workers have been able to 
access this skeleton, as shown in Scheme 65. 
Scheme 65. 
Starting this time from L-tryptophan, the dihydro-β-
carboline ent-200 (accessed in 63% yield) was N-protected 
before aminal formation with in situ esterification. The 
diastereoisomeric mixture 215 was treated with 
allyltrimethylsilane 216 and boron trifluoride etherate to 
afford C3,C5-cis tetrahydro-β-carboline 217 in a 5.5:1 
diastereoisomeric ratio. The ester was then selectively 
reduced and the aldehyde reacted with the 
diazophosphonate shown to afford the alkyne in a one-pot 
procedure. This alkyne 218 underwent enyne metathesis 
(Scheme 66) with Grubbs’ first-generation catalyst 219 to 
give tetracyclic diene 220 in essentially quantitative yield. 
The monosubstituted olefin of this diene was then 
selectively cleaved with AD-mix-α79 and NaIO4 to give 
α,β-unsaturated aldehyde 221. 
Scheme 66. 
The α,β-unsaturated aldehyde 221 (10% yield from L-
tryptophan) is a differentially protected form of the 
advanced intermediate 61 reported by Cook in the 
enantiospecific syntheses of macroline/sarpagine/ajmaline 
alkaloids, as detailed in Section 2. As such, this report from 
Martin constitutes a useful alternative approach to these 
natural products, starting, as it does, from L-tryptophan. 
5. Rassat’s Synthesis of the Tetracyclic Ketone 
In 2000, Rassat and co-workers reported
80,81
 a synthesis of 
Cook’s tetracyclic ketone intermediate 10 (summarized in 
Scheme 67). The crucial strategic difference in this 
approach is that formation of the [3.3.1]bicyclic skeleton 
occurs prior to the introduction of an indole. 
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Scheme 67. 
 
Transannular cyclisation of the bis(epoxide) starting 
material 222 with benzylamine led to a regioisomeric 
mixture of bicyclic structures. The unwanted [4.2.1]bicycle 
223 may be converted into the desired [3.3.1]bicycle 224 
under conditions of trifluoroacetate formation and 
subsequent hydrolysis. Selective monoprotection of the 
resultant diol to give 225 was followed by a protecting 
group swap, giving 226. Oxidation to the ketone and 
deprotection of the other hydroxyl functionality led to the 
precursor 227 for Fischer indole synthesis of the tetracyclic 
core. This was effected in good yield with N-methyl-N-
phenylhydrazine in acidic methanol at reflux overnight. 
Reduction to 228 regenerated the original N-benzyl 
protecting group and oxidation afforded the racemate of 
Cook’s intermediate 10 in 25% overall yield. 
6. Kwon’s Formal Syntheses of (±)-Alstonerine and (±)-
Macroline 
Kwon and co-workers’ formal syntheses82 arose from their 
interest in phosphine-catalysed [4+2] annulations.
83
 This 
key reaction occurred between an indolyl imine dienophile 
230 (prepared from 229) and a diene synthetic equivalent, 
the allenyl diester 233 (prepared from 231 via 232). The 
synthesis of these two coupling partners is shown in 
Scheme 68. 
Scheme 68. 
The cyclisation of 230 and 233 proceeded in 73% yield to 
give 241 as a 3:1 mixture of diastereoisomers. The 
proposed mechanism (believed to proceed via intermediates 
234-240) is shown in Scheme 69. 
Under acidic conditions, the [4+2] product 241 underwent 
an intramolecular Friedel–Crafts acylation (Scheme 70) to 
give the tetracyclic macroline skeleton 242. Thiolate-
mediated N4-deprotection and subsequent Eschweiler–
Clarke N4-methylation both proceeded in essentially 
quantitative yield to give 243. NaBH4 and ZnI2 effected 
benzylic ketone reduction (along with formation of the N4-
borane adduct, 244; the N-B bond was cleaved by heating 
to reflux in EtOH). DIBAL-H ester reduction gave the 
tetracyclic allyl alcohol rac-37. 
Scheme 69. 
Racemic alcohol rac-37 (31% yield, longest linear 
sequence) is an advanced intermediate in Cook’s syntheses 
of alstonerine 44 and macroline 1 (see Sections 2.2 and 
2.9). 
Scheme 70. 
7. Kuethe’s Aza-Diels–Alder/Intramolecular Heck 
Approach 
Kuethe and co-workers
84
 have also adopted a [4+2] 
annulation strategy for construction of the tetracyclic 
macroline core. Adapting the work of Waldmann,
85
 they 
employed Danishefsky’s diene 248 with an imine derived 
from 245 (via 246 and 247), the connectivity of which was 
different to that used by Martin, in that it was derived from 
an indole substituted at the C7-position, not the C2-
position. The cyclisation is shown in Scheme 71. 
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Scheme 71. 
Kuethe’s group then attempted the synthesis of the desired 
tetracyclic system under conditions of both transmetallation 
and radical initiation. In both instances, however, the 
substrate 249 was simply deiodinated at the indolyl 
2-position. The desired cyclisation was eventually effected 
by the use of palladium, giving 251 (Scheme 72). 
Scheme 72. 
The reaction required stoichiometric amounts of Pd
II
 – 
rapid deposition of palladium black was observed during 
the course of the reaction. The inability of the reaction to 
go to completion under catalytic Heck conditions is 
presumed to arise from the lack of an appropriate β-
hydrogen for elimination. The proposed intermediate anti-
252 (Scheme 73) has no β-hydrogen for syn elimination. 
Whilst isomerisation via a palladium enolate 253 is 
feasible,
86
 syn elimination still does not occur, presumably 
since it would entail the formation of a high-energy anti-
Bredt bridgehead olefin. 
Attempts at performing the catalytic Heck reaction under 
reductive conditions led only to isolation of the deiodinated 
by-products 250. When a modified Heck substrate 255 that 
contained additional β-hydrogens (the extra methyl group 
in 254 compared to 248) was prepared, this smoothly 
underwent cyclisation with 10 mol% Pd
0
 to give 256 
(Scheme 74). 
 
Scheme 73. 
Many ajmaline/sarpagine alkaloids possess a 
hydroxymethyl group at the C16 position. In order to 
introduce such a moiety, 249 was hydroxymethylated to 
give 257 prior to palladium cyclisation, as before, to give 
258. Notably, appreciable amounts of α,β-unsaturated 
ketone 259 were isolated also. This is proposed to arise by 
elimination from the palladium enolate of type 253. Whilst 
the use of stoichiometric amounts of palladium has obvious 
disadvantages, this entry to the tetracyclic macroline 
skeleton is novel and reasonably succinct (e.g. N-methyl-
258, 5 steps, 9% yield, Scheme 75). 
Scheme 74. 
Scheme 75. 
Efforts are currently under way to induce asymmetry
87
 in 
the aza-Diels–Alder cyclisation by use of a chiral amine for 
imine formation. For example, the use of the imine derived 
from (S)-α-methylbenzylamine 261 and indolyl aldehyde 
260 gave rise to dihydropyridone 262 in a 
diastereoisomeric ratio of 92:8 (Scheme 76). 
Scheme 76. 
8. Bailey’s 
Synthesis of (–
)-Raumacline 
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Like Cook, Bailey and co-workers have made extensive 
study of the Pictet–Spengler reaction and have utilised it in  
previously reported formal syntheses of ajmaline, 
koumidine and suaveoline, amongst others.
88
 Unlike Cook, 
Bailey’s syntheses have as their core strategy the use of 
C3,C5-cis-specific Pictet–Spengler reactions. This permits 
the use of L-tryptophan to access various tetrahydro-β-
carbolines having the correct configuration at C-3 and C-5 
and this approach was used in Bailey’s recent synthesis of 
raumacline
89
 (263, Scheme 77). In contrast, Cook employs 
D-tryptophan in C3,C5-trans-specific Pictet–Spengler 
reactions, followed by selective epimerisation at C-5. 
Scheme 77. 
Bailey et al. employed cyanomethyltryptamine 265 as their 
Pictet–Spengler substrate.90 It may be synthesised in 4 steps 
from the amino acid starting material on a large scale with 
no need for chromatography – the cyanosulfonamide made 
from 264 may be purified by crystallisation and the 
subsequent reductive desulfonylation has been optimised to 
provide pure 265 (Scheme 78). 
Scheme 78. 
Pictet–Spengler cyclisation of 265 with a protected β-
hydroxyaldehyde 266 gave C3,C5-cis tetrahydro-β-
carboline 267 entirely stereoselectively. The factors that 
influence the selectivity had previously been studied
91
 and 
it had been shown that in general, only for reactions of aryl 
aldehydes with tryptophan allyl ester was total C3,C5-cis 
selectivity observed. A C-3 aryl substituent would not have 
been synthetically useful in the context of raumacline, 
however. A two-carbon masked aldehyde equivalent was 
required at the C-3 position, and the use of the silylated 
hydroxyaldehyde in conjunction with the cyanomethyl 
group is both synthetically useful and cis-specific. Such a 
choice of substituents likely arose from extensive 
optimisation; for example, cyclisation of the same aldehyde 
266 with L-tryptophan methyl ester 268 gave 269 with only 
3:1 cis-selectivity (Scheme 79). 
Scheme 79. 
Once formed, tetrahydro-β-carboline 267 was N4-
benzylated and N1-methylated without complication, 
giving 270. It is probably significant that the Pictet–
Spengler reaction was performed on the N1,N4-
unsubstituted system; Cook has observed that an N4-benzyl 
substituent (or any bulky substituent) enhances C3,C5-
trans selectivity in the cyclisation. Hydroxyl deprotection 
and oxidation to 271 were routine (Scheme 80). 
Scheme 80. 
Scheme 81. 
A Horner–Wadsworth–Emmons reaction with 272 
furnished 273 (5:3 E:Z), the substrate for intramolecular 
Michael cyclisation to the tetracycle. This was induced 
with LiNEt2, giving 274 as an inseparable mixture of 
diastereoisomers. C-15 was found to have entirely R 
configuration as desired and C-16 was found to be 4:1 S:R. 
No selectivity was observed at C-18 (1:1 S:R). Bailey 
makes no comment relating the C-18 stereochemistry to 
olefin geometry or otherwise (Scheme 81).  
Scheme 82. 
After reduction, heating the resultant diastereoisomeric 
mixture 275 to reflux with catalytic toluene-4-sulfonic acid 
hydrate in THF gave a mixture of two lactones 276a/b, 
diastereoisomeric at C-18. Gratifyingly, both C-16 epimers 
had been transformed only into (16S) lactones 276a/b. 
Presumably the (16R) epimer of 275 had initially cyclised 
to the cis-decalin, before base-induced epimerisation to the 
trans-decalin structure. That the trans-decalin would be the 
lower-energy configuration may be seen from the predicted 
3D structure of (–)-raumacline (Scheme 82), where the all-
equatorial conformation is visible. The C-18 epimeric 
lactones were separated by chromatography and the isomer 
having the correct (18S) configuration (276a) underwent 
DIBAL reduction to introduce the lactol 277 (correctly 
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configured) and hydrogenolytic debenzylation to afford (–)-
raumacline 263 (Scheme 82). 
The difficulty in exerting control over the C-18 
stereochemistry is regrettable, but, nevertheless, in this 
synthesis of (–)-raumacline (7% overall yield from 
L-tryptophan), five of the six stereocentres have been 
effectively controlled, a notable achievement and a 
significant improvement on previous approaches. 
9. Bailey’s Synthesis of (–)-Suaveoline 
In addition to the earlier reported formal syntheses
88
 of 
suaveoline and ajmaline, Bailey and co-workers have made 
many and varied additional contributions
92
 to the field. 
These have culminated in a recent total synthesis of 
suaveoline.
93
 The synthesis employs the same cis-selective 
Pictet–Spengler cyclisation described in Section 8, but in 
this instance, cyanoaldehyde 271 was homologated to an 
unsaturated bis(nitrile) species 279  by means of a Horner–
Wadsworth–Emmons reaction. The phosphonate 278 was 
prepared by in-situ alkylation with ethyl iodide. A 
vinylogous Thorpe cyclisation was then effected, giving  
the tetracyclic intermediate 280 (Scheme 83). 
Scheme 83. 
Tetracycle 280 was isolated as a mixture of 
diastereoisomers, all of which were suitable for further 
elaboration to suaveoline. Completion of the synthesis was 
by DIBAL-mediated reduction of 280 to an intermediate 
diimine 281. This was treated with hydroxylamine 
hydrochloride in ethanol to effect formation of pyridine 
282. N4-Deprotection gave suaveoline 80 (6% from L-
tryptophan), idenitical with both the natural product and a 
sample of semisynthetic suaveoline prepared from 
ajmaline
93
 
(Scheme 
84). 
Scheme 
84. 
10. Ohb
a’s 
Synthes
is of (–)-
Suaveol
ine 
The  total synthesis of (–)-suaveoline reported by Ohba and 
co-workers
94
 arose from their interest in oxazole–olefin 
Diels–Alder reactions as a route to annulated pyridines. 
Formation of oxazole 284 from N4-Boc-protected L-
tryptophan methyl ester 283 occurred without erosion of ee 
according to their previously reported methodology.
95
 
Temporary removal of the protecting group was necessary 
for N-acylation (giving 285), Bischler–Napieralski reaction 
(6 days in neat POCl3, giving 286) and stereoselective 
hydrogenation (Scheme 85). 
Scheme 85. 
Upon re-introduction of the Boc group to give 287, a 
chemoselective ester to aldehyde reduction was effected 
followed by Wittig reaction to introduce the ethyl 
sidechain. The IMDA reaction of 289 was found to work 
best by heating in xylene at reflux, with addition of 1,5-
diazabicyclo[4.3.0]non-5-ene (suggested simply to be a 
scavenger for H2O), giving pyridine 290 in 69% yield.  N1-
Methylation and N4-deprotection afforded (–)-suaveoline 
80 in 10% yield from 283. The route disclosed above is 
radically different from those of Bailey and Cook – instead 
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of relying on a Pictet–Spengler reaction to install the 
crucial tetrahydro-β-carboline stereochemistry, Ohba 
employs a  diastereoselective reduction. Whilst the 
synthesis was most likely conceived primarily as a 
showcase for the pyridine-forming IMDA reaction, the 
aforementioned diastereoselective reduction may be of use 
for the synthesis of further members of the 
macroline/sarpagine/ajmaline indole class. It is noteworthy 
that, in this succinct synthesis, N1-protection was 
unnecessary (Scheme 86). 
Scheme 86. 
11. Ohba’s Synthesis of 1-Demethyl-20-
deethylsuaveoline 
In 1996, Batista et al. isolated sellowiine, a macroline-
related alkaloid, from the leaves of Rauvolfia sellowii.
96,97
 
For this natural product, they proposed the structure 1-
demethyl-20-deethylsuaveoline 294. The methodology of 
Ohba and co-workers was ideally suited to the synthesis of 
this structure and they were able to achieve a total 
synthesis
98
 (Scheme 87). 
Scheme 87. 
Elaboration of aldehyde 288 was by a Wittig reaction to 
introduce a vinyl sulfide sidechain (it was found that a 
terminal olefin was not able to undergo the intramolecular 
Diels–Alder reaction). Thus the removable thiomethyl 
group was used instead, and the IMDA reaction of 291 
gave pyridine 292 in good yield. Removal of the thiomethyl 
group from 292 by reduction with Raney-nickel (giving 
293) and trifluoroacetic acid-induced N4-deprotection gave 
1-
demet
hyl-
20-
deeth
ylsua
veoli
ne 
294 (7% yield from N4-Boc L-tryptophan methyl ester). 
The spectroscopic data recorded by Ohba and co-workers 
for 294 did not correlate with those reported for sellowiine 
by Batista; the chemistry of sellowiine remains incomplete, 
therefore. 
12. Craig’s Approach to (–)-Alstonerine 
Craig and co-workers have recently reported
99
 the results of 
their studies on the syntheses of (–)-alstonerine 44 by an 
aziridine-based approach. Using methodology reported by 
Mioskowski,
100
 they were able to generate anion 296 by 
reductive desulfonylation of bis(sulfone) 295. This in turn 
was added to L-tryptophan-derived aziridine 297 to give 
298. The cyclopentene in 298 was employed as a 
dialdehyde surrogate; in order that it could be unmasked, a 
selective oxidation of the olefin in the presence of the 
indole was necessary. After optimisation, this was found to 
be viable with tetra-n-butylammonium permanganate in 
CH2Cl2, giving 299. Subsequent diol cleavage gave 
dialdehyde 300, which underwent acid-induced Pictet–
Spengler cyclisation via 301 to tetracyclic monoaldehyde 
302 as a mixture of diastereoisomers (Scheme 88). 
Scheme 88. 
Craig’s use of the Pictet–Spengler reaction is strategically 
different from Cook’s or Bailey’s. In Bailey’s syntheses, 
cis selectivity was achieved in the Pictet–Spengler reaction 
by careful choice of reaction partners. In the current work, 
the tetrahydro-β-carboline geometry was formed 
exclusively cis, due to the cyclic nature of the iminium 
intermediate. This reversal of the order of events 
(formation of the C3-N4-C5-C16-C15-C14 ring prior to 
this intramolecular Pictet–Spengler cyclisation) neatly 
avoids stereochemical ambiguity in the cyclisation step. 
Monoaldehyde 302 was further elaborated by sulfone 
elimination and vinylogous silyl enol ether formation. The 
geometry shown for 303 was observed exclusively. 
Introduction of C17 was effected by the use of an unusual 
hetero-Diels–Alder reaction of formaldehyde. Monomeric 
formaldehyde, generated by a modified version of the 
Schlosser protocol,
101
 was reacted with 303 under 
conditions of Lewis acid catalysis to give advanced 
pentacyclic intermediate 304 (9% from L-tryptophan). It 
can be seen that introduction of a pendant 2-carbon 
fragment at C20 would permit access to the complete 
alstonerine skeleton (Scheme 89). 
Scheme 89. 
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13. Conclusions and Future Prospects 
The chemistry detailed herein shows that considerable 
advances have recently been made in the field of 
sarpagine/macroline/ajmaline indole alkaloids since the 
field was last reviewed. The Pictet–Spengler reaction 
remains a key strategic transformation for the synthesis of 
molecules of this class, as evidenced by the work of Cook, 
Bailey and Craig. Nevertheless, a diverse array of other 
reaction classes have been deployed to access the targets in 
question. In particular, Cook’s use of a common late-stage 
tetracyclic intermediate has allowed access to a large 
variety of natural products by use of varied transformations 
for the final elaborations. It is anticipated that further 
advances in the chemistry of macroline/sarpagine/ajmaline 
indole alkaloids will be reported in due course by many of 
the laboratories from which the work reviewed here 
originated. 
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